Ann Arbor, Michigan
Dr. Robert Burke, director of the Michigan Center for Cosmetic Surgery, has been appointed national key advisor for ALMI (autologous lipocyte micronized injection) procedures by Healeon Medical, a regenerative medicine company focusing exclusively on the safe harvesting and isolation of regenerative cells for use in bio-cellular therapies.
With cosmetic medicine and surgery trends in which men and women seek more natural solutions to common cosmetic concerns, “This offers expanded choices to both men and women wishing to maximize cosmetic surgical and medicine treatments, avoiding the injection and application of foreign substances,” according to Dr.Burke.
Dr. Burke also stated, “ALMI bioregenerative treatments are possible due to advances in aesthetically directed bioregenerative medicine over the past 20+ years. Better understanding of regenerative solutions and advances in the harvesting and processing of adipose-derived stem cells have resulted in remarkable treatment advances .”
Current areas where this is applied in cosmetic medicine include:
- Stimulation of hair growth in balding men and women
- Facial rejuvenation
- Hand rejuvenation
- Breast lifting
“The advantage of the ALMI bioregenerative stem cell solutions is customization for patients based on their needs using their own adipose derived stem cells for regeneration. This approach allows patients to actively participate in their more natural treatments.”
The Michigan Center for Cosmetic Surgery, directed by Robert H. Burke, MD, FACS is committed to expansion and use of bioregenerative solutions where possible, offering patients natural rejuvenation choices.
Dr. Burke is Clinical Professor of Plastic and Reconstructive Surgery and Clinical Professor of Facial Plastic Surgery at Michigan State University. He is the principal investigator in FDA approved breast implant studies by both Mentor and Allergan Corporations, and in laser and noninvasive technology research.